Adaptis Names New Sales Executive

Tuesday, October 28, 2008 General News J E 4
SEATTLE, Oct. 27 /PRNewswire/ -. Adaptis, a leading business processoutsourcing (BPO) firm exclusively serving health payers, announced today thatPaul Bessembinders has joined the sales team as the newest healthcare practiceleader, leading sales efforts in the Western territory. Bessembinders willreport to Adaptis Chief Business Development Officer, Jan Claesson.


"Paul has a deep well of experience to draw upon when helping potentialclients craft a solution from the Adaptis portfolio of BPO services(," says Claesson. Bessembinders'extensive career has ranged from the insurance industry, to IT outsourcingmanagement and enterprise-level healthcare IT sales. Most recently,Bessembinders was principal in a consulting firm, specializing in helpingclinical care providers select and negotiate terms with healthcare IT systemsproviders. Bessembinders has successfully worked in outsourcing in the well as Canada being responsible for top customers and regions includingCSI and Computer Associates.

"Adaptis has targeted an underserved segment of the market, health planswith fewer than 500,000 members. I'm excited to collaborate and assist theseplans take advantage of the efficiencies of scale and technology that have,until recently, been available to only the largest players," saysBessembinders.

About Adaptis

Adaptis, headquartered in Seattle, Wash., provides business processoutsourcing to health payers in Medicaid managed care, Medicare and commerciallines of business. Adaptis combines deep healthcare experience withindustry-leading technology to increase the efficiency of the claims paymentcycle. The Adaptis family of companies, which includes regional operationscenters in Yakima, Wash., Baltimore, Md., and majority-owned subsidiary TelaSourcing Inc., processes more than 30 million transactions per year. For moreinformation, please visit


Cheryl Isen, Isen and Company, for Adaptis

(425) 222-0779

SOURCE Adaptis


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
'Get Screened' Video Contest Throws a Spotlight on...
Memory Pharmaceuticals Announces Issuance of Key U...